Differences

This shows you the differences between two versions of the page.

--- peter_juni [2022/05/15 01:20]
liam [Studies and Publications]
+++ peter_juni [2022/08/05 04:09] (current)
liam [Abbott Laboratories]
@@ Line 85: / Line 85: @@
 ==== Abbott Laboratories ====
-Jüni serves as an unpaid member of the steering group or executive committee of trials funded by [[Abbott]] Vascular and [[St. Jude Medical]], which was acquired by Abbott Laboratories in January 2017.((Cortez, M. F. (2016, April 28). //Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion.// Bloomberg. https://www.bloomberg.com/news/articles/2016-04-28/abbott-agrees-to-buy-st-jude-medical-for-25-billion)) ((Wang, D. (2016, April 28). //Abbott-St. Jude Combination: Why It Makes Sense.// Bloomberg Daybreak: Americas. https://www.bloomberg.com/news/videos/2016-04-28/abbott-st-jude-combination-why-it-makes-sense))
+Jüni serves as an unpaid member of the steering group or executive committee of trials funded by [[Abbott]] Vascular and [[St. Jude Medical]], which was acquired by Abbott Laboratories in January 2017.((Cortez, M. F. (2016, April 28). //Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion.// Bloomberg. https://www.bloomberg.com/news/articles/2016-04-28/abbott-agrees-to-buy-st-jude-medical-for-25-billion)) ((Wang, D. (2016, April 28). //Abbott-St. Jude Combination: Why It Makes Sense.// Bloomberg Daybreak: Americas. https://www.bloomberg.com/news/videos/2016-04-28/abbott-st-jude-combination-why-it-makes-sense)) ((Jüni, P. (2021, October 4). //ICMJE Disclosure Form.// BMJ. https://web.archive.org/web/20220805012030/https://www.bmj.com/sites/default/files/attachments/bmj-article/pre-pub-history/coi_disclosure_pj_rapid.pdf))
 ==== Amgen ====
@@ Line 145: / Line 145: @@
 Funded by the [[Swiss National Science Foundation]] and the [[Swiss Heart Foundation]].((Roten, L., Goulouti, E., Lam, A., Elchinova, E., Nozica, N., Spirito, A., Wittmer, S., Branca, M., Servatius, H., Noti, F., Seiler, J., Baldinger, S. H., Haeberlin, A., de Marchi, S., Asatryan, B., Rodondi, N., Donzé, J., Aujesky, D., Tanner, H., & Reichlin, T. (2021). //Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients.// Journal of Clinical Medicine, 10(21), 4871. https://doi.org/10.3390/jcm10214871))
-Jüni was a co-investigator on a study titled “From idea to reality: COVID-19 Vaccination for Children and Youth” taking place from June 1, 2021 to May 31, 2022. It was funded by the [[Canadian Institutes of Health Research]] through an “Emerging COVID-19 Research Gaps and Priorities - Vaccines” operating grant. The intended outcome of the study is to examine vaccine safety and efficacy of [[COVID-19 vaccines]] in children and youth, to provide confidence to parents considering vaccinating their children, and increase [[vaccine|hesitancy:vaccine uptake]].
+Jüni was a co-investigator on a study titled “From idea to reality: COVID-19 Vaccination for Children and Youth” taking place from June 1, 2021 to May 31, 2022. It was funded by the [[Canadian Institutes of Health Research]] through an “Emerging COVID-19 Research Gaps and Priorities - Vaccines” operating grant.((//From idea to reality: COVID-19 Vaccination for Children and Youth.// (2021, June 1). Canadian Research Information System. https://archive.ph/RsJVt)) The intended outcome of the study is to examine vaccine safety and efficacy of [[COVID-19 vaccines]] in children and youth, to provide confidence to parents considering vaccinating their children, and increase [[vaccine hesitancy|vaccine uptake]].((Wyse, M. (2021). //Pediatric Studies.// [[COVID-19 Immunity Task Force]]. https://web.archive.org/web/20220514231409/https://www.covid19immunitytaskforce.ca/task-force-research/pediatric/))
 ===== Media Appearances =====